Brian McNamara Named CEO of Haleon

Haleon, the consumer healthcare company that was spun off from GSK, has appointed Brian McNamara as its new CEO.

McNamara has over 30 years of experience in the healthcare industry, most recently as the CEO of Cardinal Health's pharmaceutical distribution business. He has also held leadership positions at McKesson and AmerisourceBergen.

McNamara will be responsible for leading Haleon through its next phase of growth. The company has a portfolio of well-known brands, including Advil, Sensodyne, and ChapStick, and it is looking to expand its reach in emerging markets.

McNamara's appointment is a sign of Haleon's commitment to growth. The company has been investing heavily in new products and markets, and it is looking to McNamara to help it achieve its goals.

McNamara is a well-respected leader in the healthcare industry, and he is expected to bring a wealth of experience and expertise to Haleon. He is also known for his strong execution skills, which will be essential for Haleon as it looks to grow its business.

McNamara's appointment is a positive sign for Haleon. The company has a strong portfolio of brands and a clear growth strategy, and McNamara is the right person to lead it into the future.

Here are some of McNamara's key goals for Haleon:

• Grow the company's revenue in emerging markets.
• Expand Haleon's portfolio of products.
• Improve the company's operating efficiency.

McNamara is confident that Haleon can achieve these goals, and he is excited to lead the company into the future.

Haleon is a global leader in consumer healthcare, and McNamara is the right person to lead the company into the future. With his experience and expertise, McNamara is well-positioned to help Haleon achieve its goals and continue to grow its business.